E17D (p.Glu17Asp) variant of TP53 (Cellular tumor antigen p53)
E17D (p.Glu17Asp) in TP53 (Cellular tumor antigen p53) is a missense change. Clinical records from EBI and UniProt describe it as uncertain significance in the context of in a sporadic cancer. The available variant effect predictions contribute to a CATVariant prioritization score of 0.25 / 1. The record also includes experimental measurements and structural context.
E17D (p.Glu17Asp) variant details
- p.Glu17Asp
- Ensembl rs2151047501
- UniProt VAR 044551
- Uncertain significance
- in a sporadic cancer
- Missense
- Variant Prioritization Score for Impact Estimate 0.251
- ESM-1b 0.00
- AlphaMissense 0.26
- EBI: Variant of uncertain significance (in a sporadic cancer)
- UniProt: Uncertain significance (in a sporadic cancer)
- Structural context available
- p53 variant effect measured by cell growth: score -2.25